Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07203833) titled 'Diagnostic and Prognostic Evaluation of Vasorin During Septic Shock' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Centre Hospitalier Universitaire, Amiens
Condition:
Vasorin
Septic Shock
Shock
Biomarker
Infection
Intervention:
Biological: blood sample
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 2025
Target Sample Size: 144
Countries of Recruitment:
France
To know more, visit https://clinicaltrials.gov/study/NCT07203833
P...